P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

NCT04249947 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Study closed

Conditions

Prostatic Neoplasms, Castration-Resistant
Neoplasms by Histologic Type
Neoplasms, Prostate
Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Neoplasms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Prostatic Disease
Salivary Gland Cancer
Salivary Gland Tumor
Adenoid Cystic Carcinoma
Salivary Duct Carcinoma
Mucoepidermoid Carcinoma
Acinic Cell Tumor

Interventions

BIOLOGICAL: P-PSMA-101 CAR-T cells
DRUG: Rimiducid

Sponsor

Poseida Therapeutics, Inc.